|
|
|
|
|
David R Katerere
Pág. 61 - 65
Drug-drug and drug-herb interactions must be considered in both pre-clinical studies and clinical use. This study set out to investigate the possible interactions caused by extracts of Sutherlandia frutescens (Sutherlandia) at drug transporter ...
ver más
|
|
|
|
|
|
|
|
|
|
|
Itumeleng H. Mabusa, Rachmond Howard, Peter Masoko
Pág. 8 bladsye
Sutherlandia frutescens (L) R. Br. contains several essential, bioactive compounds with clinically proven pharmacological activities. Sutherlandia is prescribed for people with tuberculosis but it is still not known what compounds in this plant...
ver más
|
|
|
|
|
|
|
|
|
|
|
Itumeleng H. Mabusa, Rachmond Howard, Peter Masoko
Pág. 8 bladsye
Sutherlandia frutescens (L) R. Br. bevat verskeie essensiële bioaktiewe verbindings met farmakologiese aktiwiteit waarvoor daar kliniese bewyse bestaan. Sutherlandia word vir mense met tuberkulose voorgeskryf, maar niemand weet nog watter verbi...
ver más
|
|
|
|
|
|
|
|
|
|
|
C.J.J. Vorster, A. M. Joubert
Pág. 1 page
|
|
|
|
|
|